Chinese medical robot developer TMiRob announced on Tuesday that it has completed a series B+ round of financing in the first quarter of 2019 from several investment units of Spinnotec, a state-owned venture capital platform in Shanghai.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access Over 11,000 stories and data posts over the past 8 years!
Register NowAlready have an account or paid subscription? Log in
